Impact Factor
4.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.48
3,238 total citations
h5-index
76
h5 depth signal
Cited share
53.9%
216 of 401
Total citations
3,238
Citation footprint
Metric signal
7.24
External metric anchor
Self-citation
1.6%
52 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
669
United Kingdom
289
Italy
244
France
241
Germany
204
Citing Fields of Research
Hematology
977
Lymphomas
435
Oncology
188
Immunology
138
Clinical Laboratory Science
65
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,033
Articles tracked across the journal lifetime
Indexed publication set
401
216 cited publications
Last 12 months
158
13.2 publications/month
Open access share
7.6%
12 OA publications in the last year
Leading citing country
United States
669 citing publications
Leading citing field
Hematology
977 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v2n1, Jan. 2015-
v2n1, Jan. 2015- ; selected citations only before this date
Research Focus & Classification
Indexed Subjects
Hematology
Lymphomas
Broad Categories
Hematology
Neoplasms
Lymphomas
MeSH Descriptors
Hematologic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/s2352-3026(26)00247-4
Open DOI
Phenotype, treatment, and determinants of prognosis in Erdheim–Chester disease: an international, retrospective, cohort study
02
DOI 10.1016/s2352-3026(26)00190-0
Open DOI
Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia
03
04
DOI 10.1016/s2352-3026(26)00261-9
Open DOI
Hydroxyurea benefits for sickle cell anaemia in sub-Saharan Africa
05
DOI 10.1016/s2352-3026(26)00222-x
Open DOI
α-thalassaemia: an overlooked disease entering a new era
06
DOI 10.1016/s2352-3026(26)00248-6
Open DOI
Rethinking anti-BCMA T-cell engager design
07
08
DOI 10.1016/s2352-3026(26)00263-2
Open DOI
From survival to self-determination: the chronic warrior
09
DOI 10.1016/s2352-3026(26)00262-0
Open DOI
From pain to purpose: my thalassaemia journey
10
DOI 10.1016/s2352-3026(26)00257-7
Open DOI
Thalassaemia revisited: whose progress?
Bibliographical & Catalog Notes
Volume 1 complete in three issues.
Numbering from the contents page.